JPH0352806A - Hair-raising agent - Google Patents
Hair-raising agentInfo
- Publication number
- JPH0352806A JPH0352806A JP18631789A JP18631789A JPH0352806A JP H0352806 A JPH0352806 A JP H0352806A JP 18631789 A JP18631789 A JP 18631789A JP 18631789 A JP18631789 A JP 18631789A JP H0352806 A JPH0352806 A JP H0352806A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- agent
- phase
- raising
- pyridinemethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 210000004209 hair Anatomy 0.000 claims description 48
- 230000000694 effects Effects 0.000 abstract description 28
- 239000003795 chemical substances by application Substances 0.000 abstract description 15
- PTMBWNZJOQBTBK-UHFFFAOYSA-N pyridin-4-ylmethanol Chemical compound OCC1=CC=NC=C1 PTMBWNZJOQBTBK-UHFFFAOYSA-N 0.000 abstract description 8
- 201000004384 Alopecia Diseases 0.000 abstract description 7
- 150000001413 amino acids Chemical class 0.000 abstract description 4
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 239000000839 emulsion Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 229940124549 vasodilator Drugs 0.000 abstract description 3
- 239000003071 vasodilator agent Substances 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000002674 ointment Substances 0.000 abstract description 2
- 239000004131 EU approved raising agent Substances 0.000 abstract 1
- 235000010855 food raising agent Nutrition 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- -1 and among these Chemical compound 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000003676 hair loss Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 230000003658 preventing hair loss Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 3
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- WNJSKZBEWNVKGU-UHFFFAOYSA-N 2,2-dimethoxyethylbenzene Chemical compound COC(OC)CC1=CC=CC=C1 WNJSKZBEWNVKGU-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical group [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- YEIGUXGHHKAURB-UHFFFAOYSA-N viridine Natural products O=C1C2=C3CCC(=O)C3=CC=C2C2(C)C(O)C(OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-UHFFFAOYSA-N 0.000 description 1
- 235000021468 vitamin B8 Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は優れた脱毛防止、発毛効果等の養毛作用を持つ
養毛科に関する。本発明は、特に医薬品、医薬部外品、
或は化粧品分野において利用される。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a hair nourishing product that has excellent hair nourishing effects such as hair loss prevention and hair growth effects. The present invention is particularly applicable to pharmaceuticals, quasi-drugs,
Or used in the cosmetics field.
し従来の技術1
従来より、禿や脱毛の原因としては、毛根、皮脂腺等の
器官における男性ホルモンの活性化、毛包への血流量の
低下、皮脂の分泌過剰、過酸化物の生成等による頭皮の
異常等が考えられている。Conventional Technology 1 Conventional causes of baldness and hair loss include activation of male hormones in organs such as hair roots and sebaceous glands, decreased blood flow to hair follicles, excessive secretion of sebum, and production of peroxides. Scalp abnormalities are suspected.
このため従来の養毛料には、前記の原因を取り除いたり
、または、軽減する作用を持つ化合物が一般に配合され
ている。For this reason, conventional hair nourishing products generally contain compounds that have the effect of eliminating or alleviating the above-mentioned causes.
例えば、ビタミンB8、ビタミンE等のビタミン類、セ
リン、メチオニン等のアミノ酸類、センブリエキス、ア
セチルコリン誘導体などの血管拡張剤、紫根エキス、ヒ
ノキチオール等の抗炎症剤、エストラジオールなどの女
性ホルモン剤、セファランチンなどの皮膚機能冗進剤な
どが配合され、脱毛症の予防および治療に用いられてい
る。For example, vitamins such as vitamin B8 and vitamin E, amino acids such as serine and methionine, vasodilators such as Oriental japonica extract, acetylcholine derivatives, purple root extract, anti-inflammatory agents such as hinokitiol, female hormones such as estradiol, cephalanthine, etc. It is formulated with skin function enhancers and is used for the prevention and treatment of alopecia.
[発明が解決しようとする課題]
〜 ・の 1占
しかしながら、前記のように種々の試みがなされている
にもかかわらず、従来の養毛料ではその脱毛防止、発毛
効果等の養毛作用は必ずしも充分なものではなかった。[Problems to be solved by the invention] - However, despite various attempts as described above, conventional hair nourishing products have no hair nourishing effects such as hair loss prevention and hair growth effects. It wasn't always enough.
これらはおそらく、脱毛の原因がさまざまであり、また
発毛の機構も非常に複雑であるためであると考えられて
いる。This is probably because the causes of hair loss are various and the mechanism of hair growth is also very complex.
見見曵且奴
本発明者は、上記のように養毛作用が不充分であること
にに鑑み、脱毛に対して有効であり、優れた脱毛防止、
発毛効果等の養毛作用を持つ物質を探求した結果、ニコ
チニックアルコールが強力な養毛作用を持つことを見出
し、本発明を完成するに至った。In view of the insufficient hair growth effect as described above, the present inventors have developed a method that is effective against hair loss and excellent in preventing hair loss.
As a result of searching for substances that have a hair-growth effect and other hair-nourishing effects, the inventors discovered that nicotinic alcohol has a strong hair-nourishing effect, leading to the completion of the present invention.
[課題を解決するための手段]
すなわち、本発明はニコチニックアルコールを有効成分
として配合することを特徴とする養毛料を提供するもの
である。[Means for Solving the Problems] That is, the present invention provides a hair nourishment characterized by containing nicotinic alcohol as an active ingredient.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明で使用するニコチニツクアルコールは、化学名で
言うと2−ビリジンメタノール、3−ビリジンメタノー
ル、4−ピリジンメタノールの3つの置換体であり、こ
れらの中で3−ピリジンメタノールが特に好ましい。The nicotinic alcohol used in the present invention has three chemical names: 2-pyridine methanol, 3-pyridine methanol, and 4-pyridine methanol, and among these, 3-pyridine methanol is particularly preferred.
本発明で使用する2−ピリジンメタノール、3−ピリジ
ンメタノール、4−ビリジンメタノールは公知の方法で
得られるものであり、その配合量は本発明の養毛料中、
0.001〜20重量%、好ましくは0.1〜10重量
%である。0.001重量%未満であると、本発明の効
果が充分得られず、20重量%を超えると製剤上好まし
くない。2-pyridine methanol, 3-pyridine methanol, and 4-pyridine methanol used in the present invention are obtained by known methods, and the blending amounts are as follows in the hair nourishment of the present invention:
It is 0.001 to 20% by weight, preferably 0.1 to 10% by weight. If it is less than 0.001% by weight, the effect of the present invention cannot be sufficiently obtained, and if it exceeds 20% by weight, it is unfavorable in terms of formulation.
本発明に係る養毛科には上記ビリジンメタノールのほか
、塩化力ルブロニウム、センブリエキス、アセチルコリ
ン誘遵体等の血管拡張剤、セリン、メチオニン等のアミ
ノ酸類、ビタミンBS、ビタミンE及びその誘導体、ビ
オチン等のビタミン預、バントテン酸及びその誘導体、
グリチルレチン酸及びその誘導体、ニコチン酸ヘンジル
などのニコチン酸エステル類、セファランチン等の皮膚
機能冗進剤、エストラジオール等の女性ホルモン剤等を
同時に配合してもよい。さらに、通常、養毛科に用いら
れる添加剤、例えば、ヒノキチオール、ヘキサク口ロフ
エン、ペンザルコニウムクロリド、セチルピリジニウム
クロリド、ウンデシレン酸、トリクロロ力ルバニリドお
よびピチオノール等の抗菌剤、メントール等の清涼剤、
サリチル酸、亜鉛およびその誘導体、乳酸およびそのア
ルキルエステルなどの薬剤、クエン酸等の有機酸類、ア
ルギニン等のアミノ酸類、オリーブ油、スクワラン、流
動バラフィン、イソプロビルミリステート、高級脂肪酸
、高級アルコール等の油分、グリセリン、プロビレング
リコール等の多価アルコール、その他界面活性剤、香料
、酸化防止剤、紫外線吸収剤、色素、エタノール、水、
保湿剤、増粘剤等が本発明の効果を損なわない範囲で適
宜配合することかできる。In addition to the above-mentioned viridine methanol, the hair nourishing agents according to the present invention include vasodilators such as rubronium chloride, Oriental japonica extract, and acetylcholine inducers, amino acids such as serine and methionine, vitamin BS, vitamin E and its derivatives, and biotin. Vitamin deposits such as bantothenic acid and its derivatives,
Glycyrrhetinic acid and its derivatives, nicotinic acid esters such as henzil nicotinate, skin function enhancers such as cephalanthine, female hormones such as estradiol, etc. may be simultaneously blended. Additionally, additives commonly used in hair care, such as antibacterial agents such as hinokitiol, hexagonal chloride, penzalkonium chloride, cetylpyridinium chloride, undecylenic acid, trichlororuvanilide, and pithionol, and cooling agents such as menthol;
Salicylic acid, zinc and its derivatives, drugs such as lactic acid and its alkyl esters, organic acids such as citric acid, amino acids such as arginine, oils such as olive oil, squalane, liquid paraffin, isoprobyl myristate, higher fatty acids, higher alcohols, Polyhydric alcohols such as glycerin and propylene glycol, other surfactants, fragrances, antioxidants, ultraviolet absorbers, pigments, ethanol, water,
Moisturizers, thickeners, and the like can be added as appropriate to the extent that they do not impair the effects of the present invention.
本発明の養毛科の性状は、波状、乳液、軟膏など外皮に
適用できる性状のものであればいずれでもよい。The hair nourishing product of the present invention may have any shape as long as it can be applied to the outer skin, such as wavy, milky lotion, or ointment.
本発明の養毛科は皮膚に直接に塗布または散布する経皮
投与による投与方法をとる。また、木発明の養毛料の投
与量は、年齢、個人差、病状等により変化するので明確
には確定てきないが、一般に人に投与する場合の投与量
は体重1kgおよび1日当り0.01〜100mg,好
ましくは0.1〜10mgであり、この量を1日1回ま
たは2〜4回に分けて投与することができる。The hair care treatment of the present invention employs a transdermal administration method in which it is directly applied or sprayed on the skin. In addition, the dosage of the hair nourishing agent of the tree invention cannot be clearly determined as it varies depending on age, individual differences, medical conditions, etc., but in general, the dosage when administered to humans is 0.01 to 1 kg per body weight and per day. The amount is 100 mg, preferably 0.1 to 10 mg, and this amount can be administered once a day or in 2 to 4 divided doses.
[実施例]
次に実施例をあげて本発明の養毛料の製法および養毛作
用をさらに具体的に説明する。本発明はこれにより限定
されるものではない。配合量は重五%である,
(製造法)
95%エタノールに3−ピリジンメタノールおよび硬化
ヒマシ油エチレンオキシド(40モル)付加物を添加し
、撹拌溶解させ、次いでイオン交換水を添加、混合して
実施例1の液状の養毛科を得た。実施例2〜12並びに
比較例1も実施例1と同様にして得た。[Example] Next, the method for producing the hair nourishing agent and the hair nourishing effect of the present invention will be explained in more detail with reference to Examples. The present invention is not limited thereby. The blending amount is 5% by weight. (Production method) Add 3-pyridine methanol and hydrogenated castor oil ethylene oxide (40 mol) adduct to 95% ethanol, stir and dissolve, then add ion-exchanged water and mix. Liquid hair growth of Example 1 was obtained. Examples 2 to 12 and Comparative Example 1 were also obtained in the same manner as Example 1.
〔発毛試験]
実施例1〜12および比較例1の発毛試験を毛周期の休
止期にあるC3H/HeNCrJマウスを用い、小川ら
の方法(ノーマル アンド アブノーマル エビダーマ
ル ディファレンシェーション[Hormal an
d Abnormal Epidermal D
ifferentiation]、M,Seijiおよ
びI.A.Bernstein編集、第159−170
ページ、1982年、東大出版)により行なった。[Hair Growth Test] The hair growth tests of Examples 1 to 12 and Comparative Example 1 were conducted using C3H/HeNCrJ mice in the resting phase of the hair cycle using the method of Ogawa et al.
d Abnormal Epidermal D
ifference], M. Seiji and I. A. Edited by Bernstein, No. 159-170
Page, 1982, University of Tokyo Press).
すなわち、マウスをl群10匹とし、無塗布、実施例1
〜12および比較例1の13群に分け、バリカンおよび
シェーバーでマウスの背部を剃毛し、それぞれのサンプ
ルを1日1回、0.1 mlずつ塗布した。各サンプル
の発毛効果はマウス背部の発毛部分を測定して面積比に
よって比較した。各サンプルによる50%発毛率に要す
る日数を表3に示した。That is, there were 10 mice in group l, no application, Example 1.
The mice were divided into 13 groups (12 to 12 and Comparative Example 1), the backs of the mice were shaved with clippers and a shaver, and 0.1 ml of each sample was applied once a day. The hair growth effect of each sample was compared by measuring the hair growth area on the back of the mouse and comparing the area ratio. Table 3 shows the number of days required for 50% hair growth rate for each sample.
表3 マウスの発毛試験結果 以上のように、 本発明に係わる養毛科は、 優れた 発毛効果を有している。Table 3 Mouse hair growth test results As mentioned above, The hair care department related to the present invention is Excellent It has a hair growth effect.
[養毛作用試験]
次に本発明の養毛科の脱毛防止、発毛効果等の養毛作用
を調べるために、人に対して、トリコグラム試験を実施
した。実施例1〜12、比較例■の養毛料について行な
った。[Hair nourishing effect test] Next, in order to examine the hair nourishing effects such as hair loss prevention and hair growth effects of the hair restorer of the present invention, a tricogram test was conducted on humans. The test was carried out on the hair nourishing products of Examples 1 to 12 and Comparative Example (2).
(トリコグラム試験)
養毛料の使用前と使用後の抜去毛髪の毛根を顕微鏡下で
観察し、毛根の形態から休止期毛根数を計数し、その割
合の増減によって養毛科の養毛作用を比較した。休止期
毛根とは成長の止まった毛の毛根であり、脱毛を訴える
人は正常な人よりもこの休止期毛根の割合が多いことが
認められている。(Trichogram test) Observe the removed hair roots under a microscope before and after using the hair tonic, count the number of resting hair roots from the shape of the hair root, and determine the hair nourishing effect of the hair tonic by increasing or decreasing the ratio. compared. Telogen hair roots are hair roots that have stopped growing, and it is recognized that people who complain of hair loss have a higher proportion of hair roots in the telogen phase than normal people.
実施例1〜12および比較例lの各養毛料をそれぞれ男
性被験者10名の頭皮に1日2回、1回2mlずつ6カ
月間連続して塗布し、塗布直前および6カ月間塗布終了
直後に被験者l名につき100本ずつ毛髪を抜去し、そ
れぞれの毛根を調べた。結果を表4に示した。Each of the hair nourishing agents of Examples 1 to 12 and Comparative Example 1 was applied to the scalps of 10 male subjects twice a day at a rate of 2 ml each time for 6 months, immediately before application and immediately after the end of 6 months of application. One hundred hairs were removed from each subject, and the roots of each hair were examined. The results are shown in Table 4.
表4
ト
リコグラム試験結果
以上のように本発明に係る養毛料は、優れた養毛作用を
有している。Table 4 Trichogram test results As described above, the hair nourishing agent according to the present invention has an excellent hair nourishing effect.
実施例13
(A 相)
3−ビリジンメタノール
ボリオキシエチレン(60モル)付カロ硬化ヒマシ油グ
リセリン
ジブロビレングリコール
1,3−ブチレングリコール
ボリエチレングリコール1500
(B 相)
セチルイソオクタネート
スクワラン
ワセリン
プロビルパラベン
(C 相)
カルポキシビニルポリマー1%水溶液
へキサメタリン酸ソーダ
イオン交換水
1.0
2.0
10.0
10.0
5.0
5.0
10.0
5.0
2.0
2.0
30.0
0.03
8,35
(D 相)
イオン交換水
(E 相)
カセイカリ
イオン交換水
4.5
0.12
5.0
(製造法)
A相、B相をそれぞれ60℃で加熱溶解し、混合してホ
モミキサー処理しゲルを作る。これにI)相を徐々に添
加しホモミキサーで分散する。Example 13 (Phase A) 3-pyridine methanol polyoxyethylene (60 mol) with calohydrogenated castor oil glycerin dibrobylene glycol 1,3-butylene glycol polyethylene glycol 1500 (Phase B) cetyl isooctane squalane vaseline probil Paraben (phase C) Carpoxyvinyl polymer 1% aqueous solution Sodium hexametaphosphate ion-exchanged water 1.0 2.0 10.0 10.0 5.0 5.0 10.0 5.0 2.0 2.0 30 .0 0.03 8,35 (D phase) Ion exchange water (E phase) Caustic ion exchange water 4.5 0.12 5.0 (Production method) Phase A and phase B were dissolved by heating at 60°C. , mix and process with a homomixer to make a gel. Phase I) is gradually added to this and dispersed using a homomixer.
次にこれに溶解したC相を加え、最後に溶解したE相を
添加しホモミキサーで乳化してO / W乳液型の養毛
料を得た。Next, the dissolved phase C was added thereto, and finally the dissolved phase E was added and emulsified with a homomixer to obtain an O/W emulsion type hair nourishment.
この養毛料を実施例1と同様に人に対して、実使用テス
トを行ったところ、その養毛作用が優れていることが確
認された。When this hair nourishing agent was tested on humans in the same manner as in Example 1, it was confirmed that its hair nourishing effect was excellent.
実施例14
(A 相)
3−ビリジンメタノール
5.0
流動パラフィン 5・0セトステ
アリルアルコール 5,5グリセリルモノス
テアレート 3.0EO (20モル)−2−
オクチルドデシルエーテル3.0プロビルパラベン
0.3香料
0.1(B 相)
グリセリン 8.0ジプロピレ
ングリコール 20.0ポリエチレングリ
コール4000 5.0へキサメタリン酸ソ
ーダ o.oosイオン交換水
45.095(製造法)
A相、B相をそれぞれ加熱溶解して混合し、ホモミキサ
ーで乳化してクリーム状養毛料を得た。Example 14 (Phase A) 3-pyridine methanol 5.0 Liquid paraffin 5.0 Cetostearyl alcohol 5,5 Glyceryl monostearate 3.0 EO (20 mol) -2-
Octyl Dodecyl Ether 3.0 Probylparaben
0.3 fragrance
0.1 (Phase B) Glycerin 8.0 Dipropylene glycol 20.0 Polyethylene glycol 4000 5.0 Sodium hexametaphosphate o. oos ion exchange water
45.095 (Production method) Phase A and phase B were respectively heated and dissolved and mixed, and emulsified with a homomixer to obtain a cream-like hair nourishing agent.
この養毛料を実施例1と同様に人に対して、実使用テス
トを行ったところ、その養毛効果が優れていることが確
認された。When this hair nourishing agent was tested on humans in the same manner as in Example 1, it was confirmed that the hair nourishing effect was excellent.
実施例15
(A 相)
4−ビリジンメタノール 10.0流動パ
ラフィン 10.5グリセリルモノ
ステアレート 3.0EO (20モル)−2
−オクチルドデシルエーテル3.0プロビルバラベン
0.3香料
0.1(B 相)
グリセリン 10.0ジプロピ
レングリコール 18.0ポリエチレング
リコール4000 5.0へキサメタリン酸
ソーダ 0.005イオン交換水
45.095(製造法)
A相、B相をそれぞれ加熱溶解して混合し、ホモミキサ
ーで乳化してクリーム状養毛料を得た。Example 15 (Phase A) 4-pyridine methanol 10.0 Liquid paraffin 10.5 Glyceryl monostearate 3.0 EO (20 mol) -2
-Octyldodecyl ether 3.0 probylbaraben
0.3 fragrance
0.1 (Phase B) Glycerin 10.0 Dipropylene glycol 18.0 Polyethylene glycol 4000 5.0 Sodium hexametaphosphate 0.005 Ion exchange water
45.095 (Production method) Phase A and phase B were respectively heated and dissolved and mixed, and emulsified with a homomixer to obtain a cream-like hair nourishing agent.
この養毛科を実施例1と同様に人に対して、実使用テス
トを行ったところ、その養毛効果か優れていることが確
認された。When this hair growth product was tested on humans in the same manner as in Example 1, it was confirmed that its hair growth effect was excellent.
実施例16
(A 相)
2−ピリジンメタノール
ポリオキシエチレン(60モル)付カロ硬化ヒマシ油グ
リセリン
1,3−ブチレングリコール
ポリエチレングリコール1500
(B 相)
セチルイソオクタネート
ワセリン
プロビルパラベン
(C 相)
カルボキシビニルボリマー■%水溶<夜へキサメタリン
酸ソーダ
イオン交換水
(D 相)
イオン交換水
(E 相)
10.0
2.0
10.0
5.0
5.0
10.0
8.0
2.0
30.O
O.03
8.35
4.5
カセイカリ
イオン交換水
0.12
5.0
(製造法)
A相、B相をそれぞれ60℃で加熱溶解し、混合してホ
モミキサー処理しゲルを作る。これにD相を徐々に添加
しホモミキサーで分散する。Example 16 (Phase A) 2-Pyridine Methanol Polyoxyethylene (60 mol) Caloride Castor Oil Glycerin 1,3-Butylene Glycol Polyethylene Glycol 1500 (Phase B) Cetyl Isooctanate Petrolatum Probyl Paraben (Phase C) Carboxy Vinyl polymer ■% water soluble < night hexametaphosphate sodium ion exchange water (D phase) ion exchange water (E phase) 10.0 2.0 10.0 5.0 5.0 10.0 8.0 2.0 30. O O. 03 8.35 4.5 Caustic ion-exchanged water 0.12 5.0 (Manufacturing method) Phase A and phase B are respectively heated and dissolved at 60°C, mixed and treated with a homomixer to form a gel. Phase D is gradually added to this and dispersed using a homomixer.
次にこれに溶解したC相を加え、最後に溶解したE相を
添加しホモミキサーで乳化してO / W乳液型の養毛
料を得た。Next, the dissolved phase C was added thereto, and finally the dissolved phase E was added and emulsified with a homomixer to obtain an O/W emulsion type hair nourishment.
この養毛料を実施例1と同様に人に対して、実使用テス
トを行ったところ、その養毛作用が優れていることが確
誌された。When this hair nourishing agent was tested on humans in the same manner as in Example 1, it was confirmed that its hair nourishing effect was excellent.
[発明の効果] 本発明の養毛料は優れた養毛効果を持つ養毛材である。[Effect of the invention] The hair nourishing material of the present invention is a hair nourishing material having an excellent hair nourishing effect.
Claims (1)
を特徴とする養毛料。A hair nourishing agent characterized by containing nicotinic alcohol as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18631789A JPH0352806A (en) | 1989-07-19 | 1989-07-19 | Hair-raising agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18631789A JPH0352806A (en) | 1989-07-19 | 1989-07-19 | Hair-raising agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0352806A true JPH0352806A (en) | 1991-03-07 |
Family
ID=16186217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18631789A Pending JPH0352806A (en) | 1989-07-19 | 1989-07-19 | Hair-raising agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0352806A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030575A (en) * | 1991-10-21 | 2000-02-29 | The Dow Chemical Company | Method for making preforms |
JP2002215892A (en) * | 2001-01-24 | 2002-08-02 | Matsushita Electric Ind Co Ltd | System for monitoring finance company |
-
1989
- 1989-07-19 JP JP18631789A patent/JPH0352806A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030575A (en) * | 1991-10-21 | 2000-02-29 | The Dow Chemical Company | Method for making preforms |
JP2002215892A (en) * | 2001-01-24 | 2002-08-02 | Matsushita Electric Ind Co Ltd | System for monitoring finance company |
JP4684424B2 (en) * | 2001-01-24 | 2011-05-18 | パナソニック株式会社 | Financial store monitoring system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100616342B1 (en) | Hair tonic composition | |
JP3220761B2 (en) | Hair restoration | |
JP2001288046A (en) | Composition for scalp and hair | |
JPH09241137A (en) | Hair crowing and restoring agent | |
JPH0352806A (en) | Hair-raising agent | |
JPH0640858A (en) | Hair tonic | |
JP2566792B2 (en) | Hair growth and hair growth promoter | |
JP2998939B2 (en) | Hair restoration | |
JPH07149614A (en) | Hair tonic agent | |
JP2787451B2 (en) | Hair restoration | |
JP2814090B2 (en) | Hair restoration | |
JP3496896B2 (en) | Hair restorer and hair cosmetic | |
JPH02164813A (en) | Hair tonic | |
JPH07206647A (en) | Hair tonic | |
JPH07277930A (en) | Hair growth material | |
JP3639389B2 (en) | Hair nourishing | |
JP2961528B2 (en) | Hair restoration | |
JPH04364109A (en) | Hair tonic | |
JPH05124937A (en) | Hair tonic | |
JPH0529322B2 (en) | ||
JPH0390014A (en) | Hair tonic | |
JP2791567B2 (en) | Hair restoration | |
JPH07228511A (en) | Hair growing agent | |
JPH03178918A (en) | Hair tonic | |
JPH04364108A (en) | Hair tonic |